International Normalised Ratio (INR)#
Plain-language guide to INR testing for patients on long-term blood thinners - what the test measures, target ranges, and how TeleTest supports monitoring.
INR is a blood test that measures how long it takes your blood to clot. It is used almost exclusively to monitor patients on the older oral blood-thinner medication that requires regular dose adjustment (often referred to as a vitamin-K antagonist). Most newer oral blood thinners do NOT require INR testing.
Request a TeleTest consultation
Important: If you are experiencing chest pressure, shortness of breath, palpitations, sudden severe headache, sudden numbness or weakness, or any active bleeding (heavy nosebleed, blood in urine or stool, blood in vomit) - go to the nearest emergency department right away.
Jump to what you need
- Understand what this test measures: What this test measures
- Know if I should get tested: Who should consider testing
- Prepare for the test: How to prepare
- Interpret my result: How to interpret your result
- Understand abnormal results: What does an abnormal result mean
- Plan retesting: Retesting and follow-up
- Order through TeleTest: Cost and coverage
What this test measures#
INR (International Normalised Ratio) is a standardized version of a clotting test called prothrombin time. It measures how quickly your blood forms a clot. INR is reported as a ratio: 1.0 is the average for a person not on any blood thinners.
When you take a vitamin-K-antagonist blood thinner, your INR rises. The goal is to keep your INR inside a specific target range that balances:
- Too low INR - blood clots too easily, risk of stroke or blood clots in legs/lungs
- In the target range ("therapeutic") - safe and effective protection against clots
- Too high INR - blood does not clot well, risk of bleeding
Why TeleTest offers INR monitoring#
Many Canadians on this older blood thinner do not have reliable access to routine INR checks at a family doctor or anticoagulation clinic, which can leave their INR drifting out of range and raise their risk of stroke or bleeding. TeleTest can order INR testing and report the result back to your prescribing clinician (family doctor or anticoagulation clinic), who manages your dose.
Important scope of TeleTest's role:
- TeleTest can order INR tests and forward your results to your prescribing clinician.
- TeleTest can adjust your blood-thinner dose based on your INR results and clinical context. Patients who are already followed by an anticoagulation clinic or specialist may prefer to keep dose adjustment with that team for continuity.
- If your INR is significantly out of range, a TeleTest clinician may call you to discuss next steps and make sure you contact your prescribing clinician promptly.
Who should consider testing#
INR is monitored regularly in patients taking the older vitamin-K-antagonist blood thinner for any of:
- Mechanical heart valve replacement
- Valvular atrial fibrillation (e.g., with mitral valve stenosis or a biological mitral valve replacement)
- History of pulmonary embolism (blood clot in the lung)
- History of deep vein thrombosis (DVT)
- Some inherited clotting disorders
- Certain cases of severe kidney or liver disease where newer oral blood thinners cannot be used safely
INR is NOT monitored for:
- Aspirin therapy
- Newer oral blood thinners (sometimes called DOACs or direct-acting oral anticoagulants - a class of medications used for atrial fibrillation and clot prevention). These do not affect INR meaningfully and are dosed by other rules.
- Injectable blood thinners given subcutaneously - monitored differently (anti-Xa levels) if monitoring is needed at all.
If you are unsure which blood thinner you take, check the pharmacy label or ask your prescribing clinician.
How to prepare#
- No fasting required.
- Take your blood thinner as you normally would on the day of the draw - do not skip a dose.
- Bring a record of:
- The name and dose of your blood thinner
- Any dose changes since your last INR
- Any new medications you have started (antibiotics, prescription anti-inflammatories, certain supplements)
- Any unusual diet changes in the past week (large changes in leafy-green-vegetable intake can affect INR)
- Any illness, vomiting, or diarrhea in the past few days
- Try to have your INR drawn at roughly the same time of day each visit, ideally close to your typical dose time.
How to interpret your result#
Target INR ranges depend on why you take the medication. Below are the standard targets used in Canada (Thrombosis Canada / CCS guidance).
| Indication | Target INR | Acceptable range |
|---|---|---|
| Non-valvular atrial fibrillation (most common reason) | 2.5 | 2.0 to 3.0 |
| Mechanical aortic valve | 2.5 | 2.0 to 3.0 |
| Mechanical mitral valve | 3.0 | 2.5 to 3.5 |
| Combined mechanical aortic and mitral valves | 3.0 | 2.5 to 3.5 |
| Mechanical pulmonic or tricuspid valve | 2.5 (pulmonic) or 3.0 (tricuspid) | Varies |
| Pulmonary embolism, treatment | 2.5 | 2.0 to 3.0 |
| Deep vein thrombosis, treatment | 2.5 | 2.0 to 3.0 |
| Some inherited clotting disorders (antiphospholipid syndrome with prior clot) | Varies - often 2.5 to 3.0 | Varies |
The reference range printed on your result form may differ slightly. Always use the target range that your prescribing clinician has set for you.
What does an abnormal result mean?#
My INR is below my target range. What does that mean?#
An INR below your target range means your blood is clotting more quickly than the medication is supposed to allow. This increases the risk of a stroke (in atrial fibrillation or mechanical valves) or a new blood clot (after DVT or pulmonary embolism).
What usually happens next:
- Your prescribing clinician will review and may increase your blood-thinner dose.
- You will likely have an earlier repeat INR (often in 1 to 2 weeks).
- You will be asked about recent changes - new medications, diet changes, missed doses, vomiting, diarrhea.
My INR is above my target range. What does that mean?#
An INR above your target means your blood is taking longer than intended to clot. This increases bleeding risk.
- Slightly above range (e.g., target 2 to 3, INR 3.2 to 3.5): usually a dose adjustment by your prescribing clinician without urgent action.
- Significantly above range (INR 4.5 to 10): more careful management, possibly holding a dose or two.
- INR above 10 OR any active bleeding: medical urgency - please go to urgent care or the emergency department right away.
Common reasons for an unexpectedly high INR:
- New antibiotic
- New non-prescription anti-inflammatory (ibuprofen, naproxen) or prescription anti-inflammatory
- New supplement (cranberry, fish oil, ginkgo, garlic, vitamin K changes)
- New prescription antifungal or antiviral
- Illness, especially with reduced food intake
- Less leafy-green vegetables than usual (lower vitamin K intake raises INR)
- Heavy alcohol use
How often should my INR be checked?#
The standard cadence:
- Just starting therapy or after a dose change: every few days to weekly until stable
- Stable, consistent INR in range: every 4 to 6 weeks (most patients)
- Long-standing stable INR (over 6 months in range): some guidelines allow up to every 12 weeks - check with your prescribing clinician
- New medication, illness, or dose change: within 5 to 7 days
- Travel, big diet change: consider an earlier check after returning
I take a newer oral blood thinner. Do I need INR checks?#
No. The newer oral blood thinners (a class sometimes called DOACs - direct-acting oral anticoagulants) do not require INR monitoring. They are dosed based on kidney function, weight, and age, with periodic checks of kidney function and blood count (CBC) instead. If your prescribing clinician has switched you to one of these newer medications, you no longer need INR monitoring.
What can make my INR change unexpectedly?#
INR is very sensitive to several factors:
Medications that often raise INR (more bleeding risk):
- Most antibiotics
- Some antifungal medications
- Some antiviral medications
- Some heart-rhythm medications
- Some thyroid medications
- Some prescription anti-inflammatory medications
Medications and substances that often lower INR (less protection):
- Some anti-seizure medications
- Some tuberculosis medications
- St. John's wort (herbal)
- High vitamin K intake (large amounts of kale, spinach, broccoli, Brussels sprouts)
Other factors:
- Illness, especially with vomiting or diarrhea
- Heavy alcohol use
- Major diet changes
- Recent travel across time zones (dose timing changes)
- Pregnancy - this medication is generally not used in pregnancy
If you start ANY new medication or supplement while on this blood thinner, please let your prescribing clinician know and arrange an INR within a week.
What is a "therapeutic" INR?#
"Therapeutic" means your INR is within the target range set by your clinician for your specific reason for being on the medication. For most atrial-fibrillation patients, that is 2.0 to 3.0. For mechanical mitral valves, it is 2.5 to 3.5. Time in therapeutic range (TTR) is a quality measure - well-managed patients spend more than 65 to 70% of their time in range.
What is INR variability and why does it matter?#
Some patients have INR that swings widely from visit to visit despite no obvious reason. Causes include:
- Genetic variation in how your liver processes the medication
- Inconsistent timing of doses
- Inconsistent diet
- Frequent illness or medication changes
- Underlying liver, kidney, or thyroid issues
If your INR is consistently unstable, your prescribing clinician may discuss switching to a newer oral blood thinner (if your reason for being on this medication allows it) or refer you to an anticoagulation clinic for more intensive monitoring.
Why do mechanical heart valves need a different INR target than atrial fibrillation?#
Mechanical valves carry a higher risk of forming clots on the valve itself, especially mitral valves. They require a higher INR target (typically 2.5 to 3.5) to keep that risk acceptably low. Most mechanical-valve patients cannot be switched to a newer oral blood thinner - the vitamin-K-antagonist medication remains the standard.
Can I take aspirin alongside my blood thinner?#
Sometimes yes, but only on your prescribing clinician's advice. The combination increases bleeding risk significantly and is typically only used in specific situations (e.g., after recent stent placement or in select mechanical-valve patients). Do not start aspirin on your own while on a blood thinner.
I'm having surgery or a dental procedure. What do I do about my blood thinner?#
This depends on:
- The type of procedure (minor dental work usually does not require stopping)
- Your bleeding and clotting risk
- Your indication for the blood thinner
Most dental cleanings and simple extractions can be done without stopping the medication. More invasive procedures (colonoscopy with polyp removal, surgery) typically require coordination between your surgeon and your prescribing clinician, sometimes with a temporary switch to short-acting injectable blood thinners ("bridging").
Please consult your prescribing clinician at least 1 to 2 weeks before any procedure.
What if I'm pregnant or planning pregnancy?#
The vitamin-K-antagonist blood thinner can harm a developing baby, especially in the first trimester. If you are pregnant or planning to become pregnant, please discuss with your prescribing clinician right away. Most patients are switched to injectable blood thinners (which do not cross the placenta) during pregnancy.
TeleTest does not currently manage pregnancy care - please see your obstetric provider for pregnancy-related anticoagulation management.
What does TeleTest do if my INR is way out of range?#
If your INR is significantly outside your target range, a TeleTest clinician may:
- Contact you to make sure you are not bleeding and to review your recent medications, illness, and diet
- Ask you to contact your prescribing clinician promptly for dose adjustment
- Recommend you go to urgent care or the emergency department if the INR is very high (above 10) or you have active bleeding
- Schedule an earlier repeat INR
TeleTest can adjust the dose of this medication based on your INR result. If you're already followed by an anticoagulation clinic or specialist for ongoing management, you may prefer to keep dose changes with that team for continuity.
Retesting and follow-up#
| Situation | Suggested INR cadence |
|---|---|
| Just started medication | Every 2 to 3 days, then weekly |
| Recent dose change | Within 5 to 7 days |
| Stable, in range | Every 4 to 6 weeks |
| Long-term stable, well-controlled | Up to every 12 weeks per some guidelines |
| New medication, illness, or major diet change | Within 5 to 7 days of the change |
| INR significantly out of range | As directed by prescribing clinician |
Cost and coverage#
- TeleTest consultation fee: out of pocket.
- INR test through your provincial health plan: typically covered when ordered for an existing indication (atrial fibrillation, mechanical valve, history of clot) by any clinician.
- TeleTest-ordered INR: generally insured for these standard indications.
When you go for your lab draw, ask the lab technician to confirm no extra "carbon copy" is being added - if your prescribing clinician or anticoagulation clinic already receives a copy automatically, that is appropriate. If you are coordinating between TeleTest and your prescribing clinician, present only the TeleTest requisition for that visit to avoid the result being misrouted.
Related pages#
- Complete Blood Count (CBC) - sometimes paired with INR monitoring
- Creatinine and eGFR - kidney function affects some blood-thinner dosing
- Blood Group - relevant for some surgical and transfusion situations
References#
Thrombosis Canada. Vitamin K Antagonist Therapy: Management of Patients on Anticoagulation. https://thrombosiscanada.ca/
Thrombosis Canada. Mechanical Valves. https://thrombosiscanada.ca/guides/pdfs/Mechanical_Valves.pdf
Thrombosis Canada. Pulmonary Embolism. https://thrombosiscanada.ca/guides/pdfs/PE.pdf
BC Guidelines: NOAC/DOAC https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/noac
Request a TeleTest consultation#
Last reviewed: Spring 2026. Reviewed by Dr. Mohan Pandit, Chief Medical Officer at TeleTest. We review this page periodically as medical guidelines, lab practices, and provincial programs evolve. This page is for general information, not personal medical advice. If you've noticed information that may be out of date or have suggestions, please contact us - we appreciate the help keeping these resources accurate.